Literature DB >> 17279465

Effect of intravenous infusion of proglumide on ruminal motility in conscious sheep (Ovis aries).

T Onaga1.   

Abstract

The effects of intravenous infusion of proglumide on regular ruminal contractions were examined in conscious sheep using doses that inhibit pancreatic exocrine secretion. After a control period of 20 min, proglumide was infused intravenously for 40 min at a dose of 15, 30 or 60 micromol/kg per min and venous blood was collected. The intravenous infusion of proglumide significantly increased the frequency of ruminal contractions at 15 micromol/kg per min without altering the amplitude, while it significantly decreased the frequency and amplitude of ruminal contractions at 30 and 60 micromol/kg per min in a dose-dependent manner. Proglumide did not increase contractile activity of the omasum, abomasum and duodenum or the plasma concentration of immunoreactive cholecystokinin (CCK). Application of proglumide at 1-30 mmol/L inhibited bethanechol-induced contraction in both longitudinal and circular muscle strips of the dorsal sac of the rumen. These results suggest that proglumide at a low dose acts indirectly on the rumen as a CCK receptor antagonist to increase the frequency of contractions, whereas at higher doses it inhibits cholinergic-induced contraction of the ruminal muscles or acts as an agonist to inhibit contractions in sheep. Hence, proglumide at high doses seems unsuitable for research or therapeutic use as a CCK receptor blockade in sheep.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17279465     DOI: 10.1007/s11259-006-0164-z

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.816


  29 in total

Review 1.  Cholecystokinin antagonists--a toxicologic perspective.

Authors:  L A Dethloff; F A de la Iglesia
Journal:  Drug Metab Rev       Date:  1992       Impact factor: 4.518

2.  Cholecystokinin receptor antagonists.

Authors:  J D Gardner; R T Jensen
Journal:  Am J Physiol       Date:  1984-05

3.  Exogenous CCK and gastrin stimulate pancreatic exocrine secretion via CCK-A but also via CCK-B/gastrin receptors in the calf.

Authors:  G Le Dréan; I Le Huërou-Luron; M Gestin; C Desbois; V Romé; C Bernard; M Dufresne; L Moroder; D Gully; J A Chayvialle; D Fourmy; P Guilloteau
Journal:  Pflugers Arch       Date:  1999-06       Impact factor: 3.657

Review 4.  Pharmacology of reticulo-ruminal motor function.

Authors:  Y Ruckebusch
Journal:  J Vet Pharmacol Ther       Date:  1983-12       Impact factor: 1.786

5.  The responses of duodenal tension receptors in sheep to pentagastrin, cholecystokinin and some other drugs.

Authors:  D F Cottrell; A Iggo
Journal:  J Physiol       Date:  1984-09       Impact factor: 5.182

6.  Gastric emptying in rats: role of afferent neurons and cholecystokinin.

Authors:  E R Forster; T Green; M Elliot; A Bremner; G J Dockray
Journal:  Am J Physiol       Date:  1990-04

Review 7.  Regulation of cholecystokinin secretion by intraluminal releasing factors.

Authors:  R A Liddle
Journal:  Am J Physiol       Date:  1995-09

8.  The cholecystokinin receptor antagonist CR1409 increases plasma cholecystokinin in rats.

Authors:  J B Jansen; A J de Jong; C B Lamers
Journal:  Regul Pept       Date:  1989-02

9.  Effects of proglumide on pancreatic acinar cell function.

Authors:  J A Williams; A Bailey; R W Steigerwalt
Journal:  Digestion       Date:  1983       Impact factor: 3.216

10.  Characterization of receptors for cholecystokinin and related peptides in mouse cerebral cortex.

Authors:  A Saito; I D Goldfine; J A Williams
Journal:  J Neurochem       Date:  1981-08       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.